Hospitalist Medicine Physicians Of Virginia - Richmond Ii, Llc - Medicare Primary Care in Mechanicsville, VA

Hospitalist Medicine Physicians Of Virginia - Richmond Ii, Llc is a medicare enrolled primary clinic (Internal Medicine) in Mechanicsville, Virginia. The current practice location for Hospitalist Medicine Physicians Of Virginia - Richmond Ii, Llc is 8260 Atlee Rd, Mechanicsville, Virginia. For appointments, you can reach them via phone at (804) 764-6000. The mailing address for Hospitalist Medicine Physicians Of Virginia - Richmond Ii, Llc is 5410 Maryland Way Ste 300, Brentwood, Tennessee and phone number is () -.

Hospitalist Medicine Physicians Of Virginia - Richmond Ii, Llc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1316583040. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (804) 764-6000.

Contact Information

Hospitalist Medicine Physicians Of Virginia - Richmond Ii, Llc
8260 Atlee Rd
Mechanicsville
VA 23116-1844
(804) 764-6000
Not Available

Primary Care Clinic Profile

Full NameHospitalist Medicine Physicians Of Virginia - Richmond Ii, Llc
SpecialityInternal Medicine
Location8260 Atlee Rd, Mechanicsville, Virginia
Authorized Official Name and PositionRobert Bessler (PRESIDENT)
Authorized Official Contact6153775658
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Hospitalist Medicine Physicians Of Virginia - Richmond Ii, Llc
5410 Maryland Way Ste 300
Brentwood
TN 37027-5339

Ph: () -
Hospitalist Medicine Physicians Of Virginia - Richmond Ii, Llc
8260 Atlee Rd
Mechanicsville
VA 23116-1844

Ph: (804) 764-6000

NPI Details:

NPI Number1316583040
Provider Enumeration Date11/18/2019
Last Update Date11/18/2019

Medicare PECOS Information:

Medicare PECOS PAC ID9234566555
Medicare Enrollment IDO20200227000002

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Medical Identifiers

Medical identifiers for Hospitalist Medicine Physicians Of Virginia - Richmond Ii, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1316583040NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Hospitalist Medicine Physicians Of Virginia - Richmond Ii, Llc acts as a billing entity for following providers:
Provider NameWayne L Smith
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1831158476
PECOS PAC ID: 5193613313
Enrollment ID: I20040309000917

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameHyunsun D Ko
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1952312258
PECOS PAC ID: 6901885615
Enrollment ID: I20040716000200

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameKavitha Krottapalli
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1134118144
PECOS PAC ID: 6103891221
Enrollment ID: I20040831001452

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameNsekenene Kolongo
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1487685301
PECOS PAC ID: 0941277263
Enrollment ID: I20040915000436

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSalman F Khan
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1528046026
PECOS PAC ID: 2769420801
Enrollment ID: I20050420000310

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameNzinga Z Teule Hekima
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1851399901
PECOS PAC ID: 4587608013
Enrollment ID: I20050615001013

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameHasan M Yousuf
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1225068968
PECOS PAC ID: 4284686510
Enrollment ID: I20050808001246

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameNoemi Romano
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1508874173
PECOS PAC ID: 3173515335
Enrollment ID: I20050915001152

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSridhar Madhunapantula
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1003821844
PECOS PAC ID: 3577597582
Enrollment ID: I20050920000536

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameHammad Hafeez
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1427044205
PECOS PAC ID: 5496774820
Enrollment ID: I20051115000879

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameRichard E Ruffin
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1922079086
PECOS PAC ID: 6800816166
Enrollment ID: I20051201000111

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameKareem B Yostos
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1568475077
PECOS PAC ID: 4284631383
Enrollment ID: I20061102000562

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameMichael E Murphy
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1639186992
PECOS PAC ID: 5991702094
Enrollment ID: I20061102000579

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameImran Ahmad
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1689889511
PECOS PAC ID: 1355434911
Enrollment ID: I20070912000677

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameFaizur Rahman
Provider TypePractitioner - Emergency Medicine
Provider IdentifiersNPI Number: 1992724520
PECOS PAC ID: 6204850977
Enrollment ID: I20071012000418

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSheron T Wyatt
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1245422351
PECOS PAC ID: 0345323283
Enrollment ID: I20080214000576

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameRazaak A Eniola
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1518902014
PECOS PAC ID: 0749298628
Enrollment ID: I20080617000042

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameMelvin L Pegram
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1083773089
PECOS PAC ID: 2264590132
Enrollment ID: I20081021000655

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameCassandra A Lewis
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1518113091
PECOS PAC ID: 9638238652
Enrollment ID: I20081106000011

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameKyaw T Zaw
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1467655076
PECOS PAC ID: 0345389680
Enrollment ID: I20091130000530

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameLubna Rana
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1023133469
PECOS PAC ID: 2466553789
Enrollment ID: I20100726000747

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameIryna Aberkorn
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1780846071
PECOS PAC ID: 7810011426
Enrollment ID: I20100903000469

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameDiego F Martinez Vasquez
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1063483188
PECOS PAC ID: 4183726854
Enrollment ID: I20101102001018

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameFariah Khan
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1568774347
PECOS PAC ID: 5991993032
Enrollment ID: I20101216000327

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameNabeel A Mohamed
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1205968732
PECOS PAC ID: 1759579972
Enrollment ID: I20110103000483

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameMark N Dumas
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1548245855
PECOS PAC ID: 9739260779
Enrollment ID: I20110211000725

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameEndalkachew G Erena
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1669631909
PECOS PAC ID: 7719169127
Enrollment ID: I20110307000495

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSally Ann Tracy Mcintosh
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1003915851
PECOS PAC ID: 5193887214
Enrollment ID: I20110415000517

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSamuel C Umesegha
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1891826202
PECOS PAC ID: 6204928666
Enrollment ID: I20110527000584

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameGerald L Quirk
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1346403474
PECOS PAC ID: 4486831062
Enrollment ID: I20110608000100

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameMahmud Uzzaman
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1578726014
PECOS PAC ID: 3476722737
Enrollment ID: I20110803000553

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NamePunit Goel
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1073761565
PECOS PAC ID: 8426228966
Enrollment ID: I20110819000217

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameVidya Nagamangala
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1720241128
PECOS PAC ID: 7719157577
Enrollment ID: I20110902000568

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameMihai F Gavris
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1306810049
PECOS PAC ID: 8820089709
Enrollment ID: I20110914000660

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameWondaya Tamene Debeb
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1063717239
PECOS PAC ID: 1759552128
Enrollment ID: I20110914000689

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameGabriella T Joffe
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1992999874
PECOS PAC ID: 8820168917
Enrollment ID: I20111027000796

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameNarayan Bhetwal
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1841418506
PECOS PAC ID: 9032205042
Enrollment ID: I20111206000522

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameKurwa Nyigu
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1417925272
PECOS PAC ID: 7416928650
Enrollment ID: I20120225000178

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameYi Sun
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1720201577
PECOS PAC ID: 0042318388
Enrollment ID: I20120508000236

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameShayasta S Mufti
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1093973687
PECOS PAC ID: 1557526027
Enrollment ID: I20120706000590

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NamePadmavathi Murakonda
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1285906602
PECOS PAC ID: 1254588809
Enrollment ID: I20120904000491

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameMargaret O Daramola
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1114126117
PECOS PAC ID: 4789729278
Enrollment ID: I20130122000388

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameBabar Hussain
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1336377613
PECOS PAC ID: 5799928529
Enrollment ID: I20130827000541

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameGuneet Sarai
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1144534546
PECOS PAC ID: 0244474401
Enrollment ID: I20130910000698

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameVidya Raghavan
Provider TypePractitioner - Hospice/palliative Care
Provider IdentifiersNPI Number: 1194955286
PECOS PAC ID: 0547404675
Enrollment ID: I20130911000599

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameJohn V Kottarathil
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1477735439
PECOS PAC ID: 4082750484
Enrollment ID: I20131004000278

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAdeola O Adeyeye
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1649432048
PECOS PAC ID: 7618149584
Enrollment ID: I20131125000511

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSaeed M Jadali
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1245526847
PECOS PAC ID: 2466683487
Enrollment ID: I20140314001401

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameFaraz Masood
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1609071661
PECOS PAC ID: 8426242066
Enrollment ID: I20140410000021

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameRosla Royal
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1770858367
PECOS PAC ID: 8921262908
Enrollment ID: I20140422000453

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAnna Villalobos
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1922270347
PECOS PAC ID: 8628217452
Enrollment ID: I20140512000829

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAnthony Oduje Isedeh
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1639445539
PECOS PAC ID: 2567688922
Enrollment ID: I20140722000768

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameNelson Enor Airewele
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1740546944
PECOS PAC ID: 8022331479
Enrollment ID: I20141216001818

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSergey Shvygin
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1760647051
PECOS PAC ID: 6103094107
Enrollment ID: I20150127000306

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameHolly M Isaacs
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1699020222
PECOS PAC ID: 8820309008
Enrollment ID: I20150615000649

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameIfeanyichukwu Chukwuma
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1356602429
PECOS PAC ID: 4284888918
Enrollment ID: I20150630001258

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAli Al-saadoon
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1316209067
PECOS PAC ID: 3678714946
Enrollment ID: I20150813012282

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameDiana V Minor
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1194109074
PECOS PAC ID: 1759696768
Enrollment ID: I20150820010443

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameJamie L Cannady
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1205207131
PECOS PAC ID: 9234439811
Enrollment ID: I20151203002888

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameBabak S Pirouz
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1609072578
PECOS PAC ID: 6103912118
Enrollment ID: I20160516001507

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameEsteban Antonio Marquez
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1851352819
PECOS PAC ID: 7315943131
Enrollment ID: I20161026000690

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameGonzalo Luizaga Coca
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1831331032
PECOS PAC ID: 7911163027
Enrollment ID: I20170207002070

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameMichelle O Hayes
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1932540747
PECOS PAC ID: 3173890118
Enrollment ID: I20170524000015

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameChristine Mary Lenore Curran
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1083834774
PECOS PAC ID: 8921160011
Enrollment ID: I20170621001990

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameMohamad Mouchli
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1821324179
PECOS PAC ID: 7618123035
Enrollment ID: I20170731003102

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameVarun K Golla
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1578856910
PECOS PAC ID: 9032331186
Enrollment ID: I20170821000982

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameOlatokunbo M Famakinwa
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1336414648
PECOS PAC ID: 3870871577
Enrollment ID: I20170821002240

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameYonis Geberemariam
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1558624619
PECOS PAC ID: 7618281270
Enrollment ID: I20170907000665

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSamuel Kebede
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1790177129
PECOS PAC ID: 6204100977
Enrollment ID: I20170919001528

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameBertha Sanchez Valdivieso
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1356571236
PECOS PAC ID: 0042462947
Enrollment ID: I20171024003696

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameMonika Bhalla
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1114368974
PECOS PAC ID: 6507153541
Enrollment ID: I20171205001440

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAhmed Hassan
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1639560162
PECOS PAC ID: 1456667088
Enrollment ID: I20180410000841

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameDavid Moh
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1295026607
PECOS PAC ID: 8224275979
Enrollment ID: I20180702002694

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameOumoul Khairi Barry
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1619358942
PECOS PAC ID: 2466744180
Enrollment ID: I20180730002312

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAnusha Kanagala
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1811384886
PECOS PAC ID: 7214285428
Enrollment ID: I20180803002407

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NamePhillip D Klahr
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1821066432
PECOS PAC ID: 4284691049
Enrollment ID: I20180810000661

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameJessica Irit Mirakov Cohen
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1255750600
PECOS PAC ID: 7315160819
Enrollment ID: I20180813000054

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAmber Marie Sholl Jenkins
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1912385790
PECOS PAC ID: 7810246659
Enrollment ID: I20180828000419

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSeme Tabassum
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1942686282
PECOS PAC ID: 4486905478
Enrollment ID: I20181002001435

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAng Zhang
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1003282427
PECOS PAC ID: 0648522631
Enrollment ID: I20181002001817

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameZeeshan Khakwani
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1417207812
PECOS PAC ID: 8123241544
Enrollment ID: I20181002003897

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAsad G Almsallam
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1740659168
PECOS PAC ID: 7416257712
Enrollment ID: I20181017002210

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameNardos Fikru Asfaw
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1952796351
PECOS PAC ID: 4981958055
Enrollment ID: I20181108002835

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAli Entezari
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1770847527
PECOS PAC ID: 3678886132
Enrollment ID: I20181112001015

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameNilsa M Jimenez
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1912153487
PECOS PAC ID: 1951620376
Enrollment ID: I20190103002251

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameJoel Nathaniel Palmer
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1952664963
PECOS PAC ID: 7113230392
Enrollment ID: I20190212003020

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAtousa Mamhmoudzadeh Tabrizian
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1013221449
PECOS PAC ID: 2860689197
Enrollment ID: I20190213002437

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NamePhilip White
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679046189
PECOS PAC ID: 8729326350
Enrollment ID: I20190312002738

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameUmar Mohammed Hardi
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1972680239
PECOS PAC ID: 7810947892
Enrollment ID: I20190313002455

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSushma Madala
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1437530003
PECOS PAC ID: 7315240199
Enrollment ID: I20190319002964

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameKevin S Sun
Provider TypePractitioner - Critical Care (intensivists)
Provider IdentifiersNPI Number: 1093154635
PECOS PAC ID: 9931440997
Enrollment ID: I20190401002310

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameLindsay Edwards Muncy
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1013322734
PECOS PAC ID: 4183942469
Enrollment ID: I20190507003067

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAshif K Jethava
Provider TypePractitioner - Nephrology
Provider IdentifiersNPI Number: 1669632782
PECOS PAC ID: 5193908879
Enrollment ID: I20190610002729

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameJames Patrick Gundersen
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1972683274
PECOS PAC ID: 9638166689
Enrollment ID: I20190813003711

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameArielle N Duncan
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1144648114
PECOS PAC ID: 2769755594
Enrollment ID: I20190822001156

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameMaitri Shah Goldman
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1730525882
PECOS PAC ID: 8921230343
Enrollment ID: I20191001002341

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameAsad Javaid
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1841652484
PECOS PAC ID: 8921390402
Enrollment ID: I20191014001998

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameTejas Raiyani
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1932336922
PECOS PAC ID: 7517113376
Enrollment ID: I20191022001775

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameChandrika Raiyani
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1881043396
PECOS PAC ID: 4789977836
Enrollment ID: I20191107001822

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameOmoye E Imoisili
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1275945396
PECOS PAC ID: 3476874371
Enrollment ID: I20191114001327

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameMichael Lucrezio
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1023382207
PECOS PAC ID: 5193957116
Enrollment ID: I20191118002737

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSarah Ann Wolcott
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1235695214
PECOS PAC ID: 2466886692
Enrollment ID: I20191223000269

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameGirmay Tewoldemedhn Asgedom
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1699129213
PECOS PAC ID: 0345674982
Enrollment ID: I20200107001814

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameSohan Varma
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1679975049
PECOS PAC ID: 8527288240
Enrollment ID: I20200303000981

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameJason Mclavy
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1639245459
PECOS PAC ID: 7214993948
Enrollment ID: I20200303001627

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameCara Smith
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1841619723
PECOS PAC ID: 2466753116
Enrollment ID: I20200914001722

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameRajeshwar Singh
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1841724457
PECOS PAC ID: 3274947460
Enrollment ID: I20210129000945

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

Provider NameBleck B Ngwafang
Provider TypePractitioner - Hospitalist
Provider IdentifiersNPI Number: 1962938803
PECOS PAC ID: 4587078654
Enrollment ID: I20210201002016

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more Medical News

› Verified 1 days ago

News Archive

Scientists find that lipocalin 2 protein disables macrophages in bacterial pneumonia

Macrophages, also known as scavenger cells, play an important role in defending against bacteria and pathogens by activating inflammatory processes. In cases of lung inflammation (pneumonia) caused by pneumococcal bacteria, this important immune response function is hampered and blocked by the protein lipocalin 2.

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

SAMHSA announces new grant program, Behavioral Health Treatment Court Collaboratives

The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.

Read more News

› Verified 1 days ago


Internal Medicine in Mechanicsville, VA

The Bon Secours Program For Diabetes Health - Memorial Regional Medica
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 8220 Meadowbridge Rd Ste 203, Mechanicsville, VA 23116
Phone: 804-764-7885    Fax: 804-559-6185
Peter L. Goodman, M. D.,inc.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 8220 Meadowbridge Rd, Suite 301, Mechanicsville, VA 23116
Phone: 804-559-0423    Fax: 804-559-1260
Bon Secours Primary Care Associates - Mechanicsville
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 7041 Lee Park Rd, Mechanicsville, VA 23111
Phone: 804-746-3505    Fax: 804-730-8038
Atlantic Knee Restoration & Regenerative Medicine - Richmond
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 7481 Right Flank Rd Ste 100, Mechanicsville, VA 23116
Phone: 256-302-2228    
Primedoc Of Richmond Pc
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 8260 Atlee Rd, Mechanicsville, VA 23116
Phone: 843-237-3378    Fax: 843-237-5073
Orthovirginia, Inc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 8200 Meadowbridge Road, Suite 100, Mechanicsville, VA 23116
Phone: 804-730-2121    Fax: 804-730-0563
Richmond Diabetes And Endocrinology - Bon Secours Medical Group
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 8266 Atlee Rd Ste 332, Mechanicsville, VA 23116
Phone: 804-764-7686    Fax: 804-764-7689

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.